RNF13 and metabolic dysfunction-associated steatohepatitis: Consistent with the phenotypes in the HFD-induced model, Rnf13 knockout intensified insulin resistance, hepatic steatosis, and liver injury in the HFHC-induced NASH model (Figs. 4b–n and 4s–t).